A prediction rule to identify allocation of inpatient care in community-acquired pneumonia

European Respiratory Journal

Volumn 21, Issue 4, 2003, Pages 695-701

  Espana P P ^a   Capelastegui, A ^a   Quintana, J M ^a   Soto, A ^a   Gorordo, I ^a   Garcia Urbaneja M ^a   Bilbao, A ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Admission decision; Community acquired pneumonia; Prediction rule; Site of care

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; COMMUNICABLE DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INFECTIOUS PNEUMONIA; INGESTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; OUTPATIENT; PLEURA EFFUSION; PREDICTION; PRIORITY JOURNAL; RESOURCE ALLOCATION; RISK ASSESSMENT; SHOCK; SOCIAL PROBLEM;

EID: 0037384268     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00057302     Document Type: Article

References (30)

1. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch Intern Med 1997; 157: 1709-1718.
2. Almirall J, Bolíbar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000; 15: 757-763.
3. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J 1997; 10: 1530-1534.
4. Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. Can Med Assoc J 2000; 162: 1415-1420.
5. McCormick D, Fine MJ, Coley CM, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?. Am J med 1999; 107: 5-12.
6. Dean NC. Use of prognostic scoring and outcome assessment tools in the admission decision for community-acquired pneumonia. Clin Chest Med 1999; 20: 521-529.
7. Halm EA, Atlas SJ, Boroswsky LH, et al. Understanding physician adherence with a pneumonia practice guideline. Effects of patient, system, and physician factors. Arch Intern Med 2000; 160: 98-104.
8. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.
9. Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010-1016.
10. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalised for community-acquired pneumonia. Ann Intern Med 1991; 115: 428-436.
11. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
12. Frias J, Gomis M, Prieto J, et al. Tratamiento antibiótico empírico inicial de la neumonía adquirida on la comunidad (Initial empirical antibiotic treatment for community-acquired pneumonia). Rev Esp Quimioterapia 1998; 11: 255-261.
13. Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-1426.
14. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) Curve. Radiology 1982; 143: 29-36.
15. Hosmer DW, Lemeshow S. Applied logistic regression. New York, John Wiley and Sons, Inc., 1989.
16. Marras TK, Gutierrez C, Chan CK. Applying a prediction rule to identify low-risk patients with community-acquired pneumonia. Chest 2000; 118: 1339-1343.
17. Menéndez R, Ferrando D, Vallés JM, Martínez E, Perpiñá M. Initial risk class and length of hospital stay in community-acquired pneumonia. Eur Respir J 2001; 18: 151-156.
18. González-Moraleja J, Sesma P, González C, López ME, García JF, Álvarez-Sala JL. What is the cost of inappropriate admission of pneumonia patients? (¿Cuál es el coste de las neumonías que ingresamos inadecuadamente?). Arch Bronconeumol 1999; 35: 312-316.
19. Ruiz A, Vallverdú M, Falguera M, et al. Community-acquired pneumonia: impact of the use of a therapeutic strategy based on probability of short-term mortality. [Neumonía adquirida on la comunidad: impacto de la utilización de una estrategia terapéutica basada en la mortalidad a corto plazo]. Med Clin (Barc) 1999; 113: 85-88.
20. Ewig S, Kleinfeld T, Bauer T, Seifert K, Schafer H, Goke N. Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. Eur Respir J 1999; 14: 370-375.
21. Flanders WD, Tucker G, Krishnadasan A, Martin D, Honig E, McClellan WM. Validation of the pneumonia severity index. Importance of study-specific recalibration. J Gen Intern Med 1999; 14: 333-340.
22. Fine MJ, Hough LJ, Medsger AR, et al. The hospital admission decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team Cohort Study. Arch Intern Med 1997; 157: 36-44.
23. Rosón B, Carratalà J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-aquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001; 33: 158-165.
24. Hasley PB, Albaum MN, Li YH, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia?. Arch Intern Med 1996; 156: 2206-2212.
25. Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 1998; 158: 1102-1108.
26. Atlas SJ, Benzer TI, Borowsky LH, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients. An intervention trial. Arch Intern Med 1998; 158: 1350-1356.
27. Marrie TJ, Lau CY, Wheeler SI, Wong CJ, Vandervoort MK, Feagan BG and for the CAPITAL Study Investigators. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000; 283: 749-755.
28. Aronsky D, Dean NC. How should we make the admission decision in community-acquired pneumonia?. Med Clin North Am 2001; 85: 1397-1411.
29. Coley CM, Li YH, Medsger AR, et al. Preferences for home vs hospital care among low-risk patients with community-adquired pneumonia. Arch Intern Med 1996; 156: 1565-1571.
30. Mortensen EM, Coley ChM, Singer DE, et al. Causes of death for patients with community-acquired pneumonia. Results from the pneumonia patients outcomes research team cohort study. Arch Intern Med 2002; 162: 1059-1064.